Woerner
06-24-2004, 07:43 AM
A new report from Ernst and Young projects federally mandated price control to force the pharmaceuticals to lower their costs. Since the Fed will be footing the bill for millions of seniors’ meds, it will surely demand price cuts to reduce the national debt.
“Devitt called for "a combination of initiatives to lower prices in the United States over time and increase prices outside the country. In this way, the burden of cost will be redistributed evenly across all industrialized nations," he said in the report.”
"Unless the pharmaceutical industry takes steps within its own ranks to effect an alternative solution, U.S. price controls, reimportation, or both seen inevitable,"
To read more go to: http://maconareaonline.com/news.asp?id=7321
“Devitt called for "a combination of initiatives to lower prices in the United States over time and increase prices outside the country. In this way, the burden of cost will be redistributed evenly across all industrialized nations," he said in the report.”
"Unless the pharmaceutical industry takes steps within its own ranks to effect an alternative solution, U.S. price controls, reimportation, or both seen inevitable,"
To read more go to: http://maconareaonline.com/news.asp?id=7321